Keywords: mircera, maintains, hb, levels, high-risk, patients, swiss

Mircera maintains Hb levels in high-risk patients

Article | 09 July 2007

Print This

Swiss drug major Roche says that an analysis of two large-scale Phase III maintenance studies of once-monthly Micera, its continuous ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in